Global Gastric Cancer Diagnostic Procedure Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06254085

Publication Date:

June 20, 2025

Pages:

140

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Gastric Cancer Diagnostic Procedure market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Gastric Cancer Diagnostic Procedure is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gastric Cancer Diagnostic Procedure is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gastric Cancer Diagnostic Procedure is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gastric Cancer Diagnostic Procedure players cover Pfizer Inc., Johnson & Johnson Co, F.Hoffmann La Roche, Merck & Co. Ilnc, Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淕astric Cancer Diagnostic Procedure Industry Forecast鈥� looks at past sales and reviews total world Gastric Cancer Diagnostic Procedure sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastric Cancer Diagnostic Procedure sales for 2025 through 2031. With Gastric Cancer Diagnostic Procedure sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastric Cancer Diagnostic Procedure industry.
This Insight Report provides a comprehensive analysis of the global Gastric Cancer Diagnostic Procedure landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastric Cancer Diagnostic Procedure portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Gastric Cancer Diagnostic Procedure market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastric Cancer Diagnostic Procedure and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastric Cancer Diagnostic Procedure.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Cancer Diagnostic Procedure market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instrument
Test Strips and Consumables
Service
Segmentation by Application:
Early Gastric Cancer
Advanced Gastric Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Johnson & Johnson Co
F.Hoffmann La Roche
Merck & Co. Ilnc
Bayer AG
Novartis AG
Bristol-Myers Squibb Company
ThermoFisher Scientific Inc
AstraZeneca plc
Abbott Laboratories Inc
Sanof SA
Eli Lilly and Company
OtsukaPharmaceutical Co Ltd
AdventHealth, Atrium Health
Astellas Pharma Inc
Bausch Health Companies Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastric Cancer Diagnostic Procedure Market Size (2020-2031)
2.1.2 Gastric Cancer Diagnostic Procedure Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gastric Cancer Diagnostic Procedure by Country/Region (2020, 2024 & 2031)
2.2 Gastric Cancer Diagnostic Procedure Segment by Type
2.2.1 Instrument
2.2.2 Test Strips and Consumables
2.2.3 Service
2.3 Gastric Cancer Diagnostic Procedure Market Size by Type
2.3.1 Gastric Cancer Diagnostic Procedure Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gastric Cancer Diagnostic Procedure Market Size Market Share by Type (2020-2025)
2.4 Gastric Cancer Diagnostic Procedure Segment by Application
2.4.1 Early Gastric Cancer
2.4.2 Advanced Gastric Cancer
2.5 Gastric Cancer Diagnostic Procedure Market Size by Application
2.5.1 Gastric Cancer Diagnostic Procedure Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gastric Cancer Diagnostic Procedure Market Size Market Share by Application (2020-2025)
3 Gastric Cancer Diagnostic Procedure Market Size by Player
3.1 Gastric Cancer Diagnostic Procedure Market Size Market Share by Player
3.1.1 Global Gastric Cancer Diagnostic Procedure Revenue by Player (2020-2025)
3.1.2 Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Player (2020-2025)
3.2 Global Gastric Cancer Diagnostic Procedure Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gastric Cancer Diagnostic Procedure by Region
4.1 Gastric Cancer Diagnostic Procedure Market Size by Region (2020-2025)
4.2 Global Gastric Cancer Diagnostic Procedure Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gastric Cancer Diagnostic Procedure Market Size Growth (2020-2025)
4.4 APAC Gastric Cancer Diagnostic Procedure Market Size Growth (2020-2025)
4.5 Europe Gastric Cancer Diagnostic Procedure Market Size Growth (2020-2025)
4.6 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Growth (2020-2025)
5 Americas
5.1 Americas Gastric Cancer Diagnostic Procedure Market Size by Country (2020-2025)
5.2 Americas Gastric Cancer Diagnostic Procedure Market Size by Type (2020-2025)
5.3 Americas Gastric Cancer Diagnostic Procedure Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastric Cancer Diagnostic Procedure Market Size by Region (2020-2025)
6.2 APAC Gastric Cancer Diagnostic Procedure Market Size by Type (2020-2025)
6.3 APAC Gastric Cancer Diagnostic Procedure Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2020-2025)
7.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Type (2020-2025)
7.3 Europe Gastric Cancer Diagnostic Procedure Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastric Cancer Diagnostic Procedure by Region (2020-2025)
8.2 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Type (2020-2025)
8.3 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gastric Cancer Diagnostic Procedure Market Forecast
10.1 Global Gastric Cancer Diagnostic Procedure Forecast by Region (2026-2031)
10.1.1 Global Gastric Cancer Diagnostic Procedure Forecast by Region (2026-2031)
10.1.2 Americas Gastric Cancer Diagnostic Procedure Forecast
10.1.3 APAC Gastric Cancer Diagnostic Procedure Forecast
10.1.4 Europe Gastric Cancer Diagnostic Procedure Forecast
10.1.5 Middle East & Africa Gastric Cancer Diagnostic Procedure Forecast
10.2 Americas Gastric Cancer Diagnostic Procedure Forecast by Country (2026-2031)
10.2.1 United States Market Gastric Cancer Diagnostic Procedure Forecast
10.2.2 Canada Market Gastric Cancer Diagnostic Procedure Forecast
10.2.3 Mexico Market Gastric Cancer Diagnostic Procedure Forecast
10.2.4 Brazil Market Gastric Cancer Diagnostic Procedure Forecast
10.3 APAC Gastric Cancer Diagnostic Procedure Forecast by Region (2026-2031)
10.3.1 China Gastric Cancer Diagnostic Procedure Market Forecast
10.3.2 Japan Market Gastric Cancer Diagnostic Procedure Forecast
10.3.3 Korea Market Gastric Cancer Diagnostic Procedure Forecast
10.3.4 Southeast Asia Market Gastric Cancer Diagnostic Procedure Forecast
10.3.5 India Market Gastric Cancer Diagnostic Procedure Forecast
10.3.6 Australia Market Gastric Cancer Diagnostic Procedure Forecast
10.4 Europe Gastric Cancer Diagnostic Procedure Forecast by Country (2026-2031)
10.4.1 Germany Market Gastric Cancer Diagnostic Procedure Forecast
10.4.2 France Market Gastric Cancer Diagnostic Procedure Forecast
10.4.3 UK Market Gastric Cancer Diagnostic Procedure Forecast
10.4.4 Italy Market Gastric Cancer Diagnostic Procedure Forecast
10.4.5 Russia Market Gastric Cancer Diagnostic Procedure Forecast
10.5 Middle East & Africa Gastric Cancer Diagnostic Procedure Forecast by Region (2026-2031)
10.5.1 Egypt Market Gastric Cancer Diagnostic Procedure Forecast
10.5.2 South Africa Market Gastric Cancer Diagnostic Procedure Forecast
10.5.3 Israel Market Gastric Cancer Diagnostic Procedure Forecast
10.5.4 Turkey Market Gastric Cancer Diagnostic Procedure Forecast
10.6 Global Gastric Cancer Diagnostic Procedure Forecast by Type (2026-2031)
10.7 Global Gastric Cancer Diagnostic Procedure Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gastric Cancer Diagnostic Procedure Forecast
11 Key Players Analysis
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Offered
11.1.3 Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Johnson & Johnson Co
11.2.1 Johnson & Johnson Co Company Information
11.2.2 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Offered
11.2.3 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Co Main Business Overview
11.2.5 Johnson & Johnson Co Latest Developments
11.3 F.Hoffmann La Roche
11.3.1 F.Hoffmann La Roche Company Information
11.3.2 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Offered
11.3.3 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 F.Hoffmann La Roche Main Business Overview
11.3.5 F.Hoffmann La Roche Latest Developments
11.4 Merck & Co. Ilnc
11.4.1 Merck & Co. Ilnc Company Information
11.4.2 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Offered
11.4.3 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck & Co. Ilnc Main Business Overview
11.4.5 Merck & Co. Ilnc Latest Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Information
11.5.2 Bayer AG Gastric Cancer Diagnostic Procedure Product Offered
11.5.3 Bayer AG Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer AG Main Business Overview
11.5.5 Bayer AG Latest Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Gastric Cancer Diagnostic Procedure Product Offered
11.6.3 Novartis AG Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis AG Main Business Overview
11.6.5 Novartis AG Latest Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Information
11.7.2 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Offered
11.7.3 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol-Myers Squibb Company Main Business Overview
11.7.5 Bristol-Myers Squibb Company Latest Developments
11.8 ThermoFisher Scientific Inc
11.8.1 ThermoFisher Scientific Inc Company Information
11.8.2 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Offered
11.8.3 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 ThermoFisher Scientific Inc Main Business Overview
11.8.5 ThermoFisher Scientific Inc Latest Developments
11.9 AstraZeneca plc
11.9.1 AstraZeneca plc Company Information
11.9.2 AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Offered
11.9.3 AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 AstraZeneca plc Main Business Overview
11.9.5 AstraZeneca plc Latest Developments
11.10 Abbott Laboratories Inc
11.10.1 Abbott Laboratories Inc Company Information
11.10.2 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Offered
11.10.3 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Abbott Laboratories Inc Main Business Overview
11.10.5 Abbott Laboratories Inc Latest Developments
11.11 Sanof SA
11.11.1 Sanof SA Company Information
11.11.2 Sanof SA Gastric Cancer Diagnostic Procedure Product Offered
11.11.3 Sanof SA Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sanof SA Main Business Overview
11.11.5 Sanof SA Latest Developments
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Information
11.12.2 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Offered
11.12.3 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eli Lilly and Company Main Business Overview
11.12.5 Eli Lilly and Company Latest Developments
11.13 OtsukaPharmaceutical Co Ltd
11.13.1 OtsukaPharmaceutical Co Ltd Company Information
11.13.2 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Offered
11.13.3 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 OtsukaPharmaceutical Co Ltd Main Business Overview
11.13.5 OtsukaPharmaceutical Co Ltd Latest Developments
11.14 AdventHealth, Atrium Health
11.14.1 AdventHealth, Atrium Health Company Information
11.14.2 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Offered
11.14.3 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 AdventHealth, Atrium Health Main Business Overview
11.14.5 AdventHealth, Atrium Health Latest Developments
11.15 Astellas Pharma Inc
11.15.1 Astellas Pharma Inc Company Information
11.15.2 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Offered
11.15.3 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Astellas Pharma Inc Main Business Overview
11.15.5 Astellas Pharma Inc Latest Developments
11.16 Bausch Health Companies Inc
11.16.1 Bausch Health Companies Inc Company Information
11.16.2 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Offered
11.16.3 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Bausch Health Companies Inc Main Business Overview
11.16.5 Bausch Health Companies Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂